Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency.
5 publications have been identified in PubMed for autosomal recessive severe congenital neutropenia due to CXCR2 deficiency. Research spans Review / Meta-Analysis (20%), Case Report / Case Series (20%), and Clinical Trial Publication (20%).
Hinke DM (2026). [PMID: 40874343](https://pubmed.ncbi.nlm.nih.gov/40874343/). *Haematologica*. [Gene Therapy / Novel Therapeutics]
Fekadu-Siebald J (2025). [PMID: 39775668](https://pubmed.ncbi.nlm.nih.gov/39775668/). *Blood advances*. [Clinical Trial Publication]
Marti S (2025). [PMID: 40510848](https://pubmed.ncbi.nlm.nih.gov/40510848/). *HemaSphere*. [Epidemiology / Natural History]
Fonseca M (2025). [PMID: 40698220](https://pubmed.ncbi.nlm.nih.gov/40698220/). *Cureus*. [Case Report / Case Series]
Katsaras G (2024). [PMID: 38921186](https://pubmed.ncbi.nlm.nih.gov/38921186/). *Hematology reports*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:58 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center